The last two decades have seen an acceleration of clinical research on, and treatment advances in, addictive illness. Much important research in this area requires the participation of subjects who themselves suffer from drug dependence and have a strong likelihood of becoming involved in the criminal justice system at some point. However, using court-supervised persons with addictive disorders in drug research raises a number of significant ethical issues. These include, among others, worries about the individual's ability to provide capable, voluntary, informed consent and the obligation of researchers to safeguard sensitive clinical information. A variety of potentially coercive factors can influence court-supervised persons in their decision whether to enter research and can compromise their ability to provide informed consent. In this paper, we explore the ethical issues arising in this research and offer some suggestions for approaches to address these concerns.
Get full access to this article
View all access options for this article.
References
1.
AdlerM. W.1995Human subject issues in drug abuse research. College on Problems of Drug Dependence. Drug and Alcohol Dependence,37 (2), 167–175
2.
AndersonJ.2001What to do about “much ado” about drug courts?International Journal of Drug Policy,12, 469–475
3.
BattjesR. J.OnkenL. S.DelanyP. J.1999Drug abuse treatment entry and engagement: Report of a meeting on treatment readiness. Journal of Clinical Psychology,55 (5), 643–657
4.
BrodyJ. L.WaldronH. B.2000Ethical issues in research on the treatment of adolescent substance abuse disorders. Addictive Behaviors,25 (2), 217–228
5.
BuchananD.KhoshnoodK.StopkaT.ShawS.SantelicesC.SingerM.2002Ethical dilemmas created by the criminalization of status behaviors: Case examples from ethnographic field research with injection drug users. Health Education Behavior,29 (1), 30–42
6.
CharlandL. C.2002Cynthia's dilemma: Consenting to heroin prescription. American Journal of Bioethics,2 (2), 37–47
CohenP. J.2002Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs. Journal of Law and Medical Ethics,30 (1), 73–81
9.
Council for International Organizations of Medical Sciences1993International ethical guidelines for biomedical research involving human subjects. Retrieved October 21, 2004, from http://www.cioms.ch/frame_guidelines_nov_2002.htm
10.
CunninghamJ. A.SobellL. C.SobellM. B.AgrawalS.ToneattoT.1993Barriers to treatment: why alcohol and drug abusers delay or never seek treatment. Addictive Behaviors,18 (3), 347–353
11.
CunninghamJ. A.SobellL. C.SobellM. B.GaskinJ.1994Alcohol and drug abusers' reasons for seeking treatment. Addictive Behaviors,19(6), 691–696
12.
DickertN.EmanuelE.GradyC.2002Paying research subjects: an analysis of current policies. Annals of Internal Medicine,136 (5), 368–373
13.
DickertN.GradyC.1999What's the price of a research subject? Approaches to payment for research participation. New England Journal of Medicine,341 (3), 198–203
14.
FieldingJ. E.TyeG.OgawaP. L.ImamI. J.LongA. M.2002Los Angeles County drug court programs: initial results. Journal of Substance Abuse Treatment,23 (3), 217–224
15.
FischerB. (In review.) “Doing good with a vengeance”: A critical assessment of the practices, effects and implications of drug treatment courts in North America. Criminal Justice
16.
FischmanM. W.JohansonC. E.1998Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behavioral Pharmacology,9 (7), 479–498
17.
FitzgeraldJ. L.HamiltonM.1997Confidentiality, disseminated regulation and ethico-legal liabilities in research with hidden populations of illicit drug users. Addiction,92 (9), 1099–1107
18.
IguchiM. Y.LondonJ. A.ForgeN. G.HickmanL.FainT.RiehmanK.2002Elements of well-being affected by criminalizing the drug user. Public Health Report, 117 Suppl 1, S146–150
19.
KleberH. D.1989Drug abuse liability testing: Human subjects issues. In FischmanM. W.MelloN. K. (Eds.), Testing for abuse liability of drugs in humans (pp. 341–356). Rockville, MD: National Institute on Drug Abuse
20.
KlineA.1997Profiles of criminal-justice clients in drug treatment: implications for intervention. Addictive Behaviors,22 (2), 263–268
21.
LeshnerA. I.1997aAddiction is a brain disease, and it matters. Science,278 (5335), 45–47
22.
LeshnerA. I.1997bDrug abuse and addiction treatment research. The next generation. Archives of General Psychiatry,54 (8), 691–694
23.
LeshnerA. I.1999Science-based views of drug addiction and its treatment. Journal of the American Medical Association,282 (14), 1314–1316
24.
LessengerJ. E.RoperG. F.2002Drug courts: a primer for the family physician. Journal of the American Board of Family Practictioners,15 (4), 298–303
25.
LoxleyW.HawksD.BevanJ.1997Protecting the interests of participants in research into illicit drug use: two case studies. Addiction,92 (9), 1081–1085
26.
MarloweD. B.MerikleE. P.KirbyK. C.FestingerD. S.McLellanA. T.2001Multidimensional assessment of perceived treatment-entry pressures among substance abusers. Psychology of Addictive Behaviors,15 (2), 97–108
27.
MarshallG. N.HserY. I.2002Characteristics of criminal justice and noncriminal justice clients receiving treatment for substance abuse. Addictive Behaviors,27 (2), 179–192
28.
McCradyB. S.BuxD. A.Jr.1999Ethical issues in informed consent with substance abusers. Journal of Consulting Clinical Psychology,67 (2), 186–193
29.
McKeganeyN.2001To pay or not to pay: respondents' motivation for participating in research. Addiction,96 (9), 1237–1238
30.
MendelsonJ. H.1991Protection of participants and experimental design in clinical abuse liability testing. British Journal of Addictions,86 (12), 1543–1548
31.
MillerN. S.FlahertyJ. A.2000Effectiveness of coerced addiction treatment (alternative consequences): a review of the clinical research. Journal of Substance Abuse Treatment,18 (1), 9–16
32.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research1978The Belmont report: Ethical principles and guidelines for the protection of human subjects of research.Bethesda, MD: Author
33.
National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction1998Effective medical treatment of opiate addiction. Journal of the American Medical Association,280(22), 1936–1943
34.
O'BrienC. P.McLellanA. T.1996Myths about the treatment of addiction. Lancet,347 (8996), 237–240
35.
O'ConnorP. G.SelwynP. A.SchottenfeldR. S.1994Medical care for injection-drug users with human immunodeficiency virus infection. New England Journal of Medicine,331 (7), 450–459
36.
PolcinD. L.WeisnerC.1999Factors associated with coercion in entering treatment for alcohol problems. Drug and Alcohol Dependence,54 (1), 63–68
37.
RappR. C.LiL.SiegalH. A.DeLibertyR. N.2003Demographic and clinical correlates of client motivation among substance abusers. Health and Social Work,28 (2), 107–115
38.
RehmJ.FischerB.HaydonE.RoomR.2003Abstinence ideology and somatic treatment for addicts-ethical considerations. Addiction Research and Theory,11 (5), 287–293
39.
RobertsL. W.2002Informed consent and the capacity for voluntarism. American Journal of Psychiatry,159 (5), 705–712
40.
SingleE.RobsonL.XieX.RehmJ.1998The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction,93 (7), 991–1006
41.
VaughnT.SarrazinM. V.SalehS. S.HuberD. L.HallJ. A.2002Participation and retention in drug abuse treatment services research. Journal of Substance Abuse Treatment,23 (4), 387–397
42.
VolkowN. D.2001Drug abuse and mental illness: progress in understanding comorbidity. American Journal of Psychiatry,158 (8), 1181–1183
43.
WalcottD. M.CerundoloP.BeckJ. C.2001Current analysis of the Tarasoff duty: An evolution towards the limitation of the duty to protect. Behavioral Science and Law,19 (3), 325–343
